Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Lot CRRE-50-0217-01 · tested by Freedom Diagnostics · 2026-02-25 · sold by Crush Research
View all Triple Agonist 50mg COAs & purity data →1,620 COAs indexed · std dev 1.42% · US
This COA is one of 2 reports the vendor published for Triple Agonist 50mg lot CRRE-50-0217-01. Panel coverage in the score above is the OR across every report in the batch — see each test below.
| Lab | Tested | Purity | Panels on this report | |
|---|---|---|---|---|
| Freedom Diagnostics(this report) | 2026-02-25 | 99.80% | Identity · Endotoxin · Net content | |
| Freedom Diagnostics | 2026-02-25 | 99.80% | Identity · Endotoxin · Net content | View → |
Both the issuing lab and the vendor independently uploaded this COA — strongest authenticity signal in our corpus.
First indexed 2026-06-07 · extracted 2026-06-07
View originalVendors who reference this batch can drop a one-line script. The verified-COA badge renders inline and the QR scans back to this page.
Disclosed Labs<script src="https://www.disclosedlabs.com/widget.js" data-lot="CRRE-50-0217-01"></script>No archived listing available for this COA's test date.
This certificate is third-party content submitted by a vendor or laboratory, or collected from a public source; Disclosed Labs does not author it and does not warrant its accuracy or authenticity. Any signals or scores shown are our opinion based on the data available to us. If you are the vendor or issuing lab and believe this report is inaccurate, forged, or should be removed, request a correction or removal — see our Copyright & Takedown Policy.